The company noted that the Non-PDT revenues were primarily driven by the sales of Nicomide which were adversely impacted by the residual levels of the ...
Non-PDT revenues were primarily driven by the sales of Nicomide® which were adversely impacted by the residual levels of the River's Edge product remaining ...
The company noted that the Non-PDT revenues were primarily driven by the sales of Nicomide which were adversely impacted by the residual levels of the ...
Non-PDT revenues were primarily driven by the sales of Nicomide(R) which were adversely impacted by the residual levels of the River's Edge product ...
Non-PDT revenues were primarily driven by the sales of Nicomide® which were adversely impacted by the residual levels of the River's Edge product remaining ...
Non-PDT revenues were primarily driven by the sales of Nicomide(R) which were adversely impacted by the residual levels of the River's Edge product ...
Non-PDT revenues were primarily driven by the sales of Nicomide® which were adversely impacted by the residual levels of the River's Edge product remaining ...
The company noted that the Non-PDT revenues were primarily driven by the sales of Nicomide which were adversely impacted by the residual levels of the ...
Non-PDT revenues were primarily driven by the sales of Nicomide® which were adversely impacted by the residual levels of the River's Edge product remaining ...
DUSA's other dermatology products include ClindaReach TM and Nicomide ® . DUSA is also researching additional indications for internal uses of Levulan PDT. ...